Chloe Stengel

Class III β-tubulin expression and in vitro resistance to microtubule targeting agents

Chloe Stengel, Stephen T. Newman, Mathew P. Leese et al. · British Journal of Cancer · 2009 · 188 citations · Full text

Dietary hyperthyroidism in dogs

B Köhler, Chloe Stengel, Reto Neiger · Journal of Small Animal Practice · 2012 · 62 citations

<i>In vivo</i> Efficacy of STX213, A Second-Generation Steroid Sulfatase Inhibitor, for Hormone-Dependent Breast Cancer Therapy

Paul Foster, Simon P. Newman, Surinder K. Chander et al. · Clinical Cancer Research · 2006 · 55 citations

Structure–Activity Relationships of C-17 Cyano-Substituted Estratrienes as Anticancer Agents

Mathew P. Leese, Fabrice Jourdan, Keira Gaukroger et al. · Journal of Medicinal Chemistry · 2008 · 52 citations · Full text

PIM and AKT kinase inhibitors show synergistic cytotoxicity in acute myeloid leukaemia that is associated with convergence on <scp>mTOR</scp> and MCL1 pathways

Koremu Meja, Chloe Stengel, Rob S. Sellar et al. · British Journal of Haematology · 2014 · 51 citations · Full text